Using Hybrid Closed-Loop Technology in Young Children with Type 1 Diabetes
L
Linda DiMeglio, MD
Primary Investigator
Overview
The purpose of this study is to understand experiences of families who are currently using or who previously used a hybrid closed loop insulin-delivery system (HCL) or sensor-augmented pump therapy (SAP) for diabetes management of their child 2-10 years old using semi-structured qualitative interviews. The qualitative data collected through the interviews from parents will inform future intervention studies designed to improve diabetes management and psychosocial outcomes of youth and parents using HCL and understand the barriers for those who no longer are using this technology.
Description
The Parent/Guardian will participate in one semi-structured qualitative interview, which will query their experiences with HCL/SAP, including: Experiences of HCL/SAP use for T1D management, how families decided to use HCL/SAP and expectations, benefits and challenges of HCL/SAP use for child (e.g., glycemic outcomes) and parents (e.g., sleep, stress), reasons for stopping HCL/SAP use (if applicable), etc. Parents will also be asked for their input on ways to intervene helpfully with families using HCL to support optimal HCL use in this population.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Diabetes
-
Age: Between 2 Years - 10 Years
-
Gender: All
Inclusion Criteria:
- (1) A child with diagnosis of presumed autoimmune Type 1 Diabetes,
- (2) A child age 2 to 10 years old (2.0-10.99) at the time of consent
- (3) A child using HCL or SAP system currently or has used HCL or SAP in the past
Exclusion Criteria:
Updated on
28 Apr 2024.
Study ID: 11743, PENDO-IIR-SHYNE
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
